Artificial Kidney
Bioartificial kidney covered in SF Chronicle, KQED Forum
The San Francisco Chronicle ran a front-page story Nov. 16 on the implantable, bio-artificial kidney project being led by UCSF bioengineer Shuvo Roy, PhD, an associate professor in the UCSF School of Pharmacy. The article includes quotes from Roy; Tejal Desai, PhD, UCSF professor of Bioengineering and Therapeutic Sciences; and from a UCSF patient. It also details how the device is intended to work, with a filtration section to remove toxins from the blood, alongside a compartment with renal cells to conduct other functions of a normal kidney, such as regulating levels of metabolites. The device is hoped to be ready for clinical trials in five to seven years, and is being developed by a multi-center team of engineers, biologists and physicians nationwide.
Ultimately, the team hopes to eliminate the need for kidney dialysis, which is used by 350,000 Americans at an annual cost of $75,000 apiece to treat kidney failure, but which is only partially effective. Roy said the number of dialysis patients has been growing up to 7 percent each year, with a quarter of those patients dying each year awaiting a kidney transplant. The project represents one of many at UCSF that are using cross-discipline collaborations to tackle some of the most pressing healthcare issues.
For additional coverage including links and video clips visit UCSF's News Center.
For more information on supporting Kidney Disease at UCSF, please contact Regan Botsford at rbotsford@support.ucsf.edu or 415/502-1573.




UCSF on Facebook
Follow us on Twitter